Lifecore Biomedical Inc.
05/22/2024 | Press release | Distributed by Public on 05/22/2024 14:31
Management Change/Compensation - Form 8-K
Item 3.02 Unregistered Sales of Equity Securities.
As described in Item 5.02 below, on May 20, 2024, Lifecore Biomedical, Inc. (the "Company") issued a restricted stock unit ("RSU") award with respect to 525,000 shares of its common stock and a performance stock unit ("PSU") award for up to 1,500,000 shares of its common stock to Paul Josephs under the Company's Equity Inducement Plan adopted on March 20, 2024.
The RSU award and PSU award were granted in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). The securities have not been registered under the Securities Act, and may not be offered or sold without registration or an applicable exemption from registration requirements. The information set forth below in Item 5.02 with respect to the Company's grants of these inducement awards to Mr. Josephs are incorporated herein by reference.